Showing results (261-270 of 976) with videos related to

Sort By:
Pageof 98
NPJ Breast Cancer|November 20, 2021
Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility studyIoannis Zerdes, Michele Simonetti, Alexios Matikas, et al.
NPJ Breast Cancer|December 3, 2021
The cytosolic iron-sulfur cluster assembly (CIA) pathway is required for replication stress tolerance of cancer cells to Chk1 and ATR inhibitorsAbena B Redwood, Xiaomei Zhang, Sahil B Seth, et al.
NPJ Breast Cancer|October 30, 2022
LINC00589-dominated ceRNA networks regulate multiple chemoresistance and cancer stem cell-like properties in HER2+ breast cancerWendong Bai, Hongyan Peng, Jiarui Zhang, et al.
NPJ Breast Cancer|October 11, 2022
Real-world study of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2- metastatic breast cancerHope S Rugo, Adam Brufsky, Xianchen Liu, et al.
NPJ Breast Cancer|September 19, 2022
Patient-reported outcomes from a randomized trial of neoadjuvant atezolizumab-chemotherapy in early triple-negative breast cancerCarlos H Barrios, Shigehira Saji, Nadia Harbeck, et al.
NPJ Breast Cancer|March 22, 2016
Tumor-associated macrophages: unwitting accomplices in breast cancer malignancyCarly Bess Williams, Elizabeth S Yeh, Adam C Soloff
NPJ Breast Cancer|October 6, 2021
Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancerDouglas Yee, Claudine Isaacs, Denise M Wolf, et al.
NPJ Breast Cancer|October 8, 2021
GnRHa protects the ovarian reserve by reducing endoplasmic reticulum stress during cyclophosphamide-based chemotherapyXiaolin Li, Sixuan Liu, Xuan Chen, et al.
NPJ Breast Cancer|October 9, 2021
Sentinel node involvement with or without completion axillary lymph node dissection: treatment and pathologic results of randomized SERC trialGilles Houvenaeghel, Monique Cohen, Pédro Raro, et al.
NPJ Breast Cancer|October 9, 2021
A careful reassessment of anthracycline use in curable breast cancerSara Alsterlind Hurvitz, Nicholas P McAndrew, Aditya Bardia, et al.
Pageof 98